In addition, NE factors were not induced in the triple-mutant clones, suggesting that the LUAD lineage is more strictly maintained than the lineage of AR-dependent prostate cancer in the context of dual p53/RB inactivation, confirming a previous study (Niederst et al., 2015). The gene discussed is ELANE; the disease is prostate carcinoma.